{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:40:06Z","timestamp":1778233206684,"version":"3.51.4"},"reference-count":54,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background: There is a lack of comprehensive reports on time trends in synchronous prostate and rectal cancers. To address this, we conducted the largest cohort study to date to assess these trends in a population-based setting.\nMethods: We included all adult (ages 18\u221299) men with incident prostate cancer in the Swedish Cancer Register in 1993\u22122019. Age-standardized incidence rates (ASIRs) of prostate cancer per 100,000 male population per year were calculated and compared to the ASIR of synchronous (\u00b1 6 months from rectal cancer diagnosis) prostate cancer. Age-adjusted synchronous-to-general incidence rate ratios (IRRs) were predicted using Poisson regression. As a sensitivity analysis to assess the effect of incidental findings due to the anatomical proximity, we investigated synchronous prostate and non-sigmoid colon cancers.\nResults: Among 238,252 prostate cancer cases, 594 were synchronous with rectal cancer. The incidence of synchronous prostate cancer increased over the study period, with mean ASIR rising from 418\/100,000 (1993\u22122001) to 788\/100,000 (year 2011\u22122019). The synchronous-to-general IRR increased from 1.92 (95% confidence interval (CI) 1.60\u22122.31) to 2.61 (95% CI 2.32\u22122.95) over the same periods. Prostate cancer was also more commonly diagnosed in conjunction with non-sigmoid colon cancer than in the overall male population, but no time trend was observed.\nInterpretation: The incidence of synchronous prostate and rectal cancers has increased over the past 20 years in Sweden, with no signs of plateauing. Future studies are warranted to explore factors contributing to prostate cancer overdiagnosis and to optimize clinical management strategies for this complex patient group.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.42592","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:36:25Z","timestamp":1741322185000},"page":"374-379","source":"Crossref","is-referenced-by-count":5,"title":["Rising incidence trends of synchronous prostate and rectal cancers: a population-based study"],"prefix":"10.2340","volume":"64","author":[{"given":"Elias","family":"Edfelt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrnoosh","family":"Shahrivar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Holmsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Radkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"102098","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","DOI":"10.3322\/caac.21660"},{"key":"102099","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"key":"102100","doi-asserted-by":"crossref","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 Update on prostate cancer epidemiology and risk factors \u2013 a systematic review. Eur Urol. 2023;84:191\u2013206.","DOI":"10.1016\/j.eururo.2023.04.021"},{"key":"102101","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021","DOI":"10.1016\/j.eururo.2023.04.021"},{"key":"102102","doi-asserted-by":"crossref","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713\u201332.","DOI":"10.1038\/s41575-019-0189-8"},{"key":"102103","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41575-019-0189-8","DOI":"10.1038\/s41575-019-0189-8"},{"key":"102104","doi-asserted-by":"crossref","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","DOI":"10.3322\/caac.21772"},{"key":"102105","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3322\/caac.21772","DOI":"10.3322\/caac.21772"},{"key":"102106","doi-asserted-by":"crossref","unstructured":"Fernandes MC, Gollub MJ, Brown G. The importance of MRI for rectal cancer evaluation. Surg Oncol. 2022;43:101739.","DOI":"10.1016\/j.suronc.2022.101739"},{"key":"102107","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.suronc.2022.101739","DOI":"10.1016\/j.suronc.2022.101739"},{"key":"102108","doi-asserted-by":"crossref","unstructured":"Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020;17:41\u201361.","DOI":"10.1038\/s41585-019-0212-4"},{"key":"102109","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41585-019-0212-4","DOI":"10.1038\/s41585-019-0212-4"},{"key":"102110","doi-asserted-by":"crossref","unstructured":"Jacobs CD, Trotter J, Palta M, Moravan MJ, Wu Y, Willett CG, et al. Multi-institutional analysis of synchronous prostate and rectosigmoid cancers. Front Oncol. 2020;10:345.","DOI":"10.3389\/fonc.2020.00345"},{"key":"102111","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fonc.2020.00345","DOI":"10.3389\/fonc.2020.00345"},{"key":"102112","doi-asserted-by":"crossref","unstructured":"Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, et al. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Pract Radiat Oncol. 2012;2:e7\u201313.","DOI":"10.1016\/j.prro.2011.11.010"},{"key":"102113","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.prro.2011.11.010","DOI":"10.1016\/j.prro.2011.11.010"},{"key":"102114","doi-asserted-by":"crossref","unstructured":"Terris MK, Wren SM. Results of a screening program for prostate cancer in patients scheduled for abdominoperineal resection for colorectal pathologic findings. Urology. 2001;57:943\u20135.","DOI":"10.1016\/S0090-4295(01)00943-8"},{"key":"102115","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0090-4295(01)00943-8","DOI":"10.1016\/S0090-4295(01)00943-8"},{"key":"102116","doi-asserted-by":"crossref","unstructured":"Enblad P, Adami HO, Glimelius B, Krusemo U, P\u00e5hlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer. 1990;65:2091\u2013100.","DOI":"10.1002\/1097-0142(19900501)65:9<2091::AID-CNCR2820650934>3.0.CO;2-M"},{"key":"102117","unstructured":"https:\/\/doi.org\/10.1002\/1097-0142(19900501)65:9%3C2091::AID-CNCR2820650934%3E3.0.CO;2-M"},{"key":"102118","doi-asserted-by":"crossref","unstructured":"Sturlud\u00f3ttir M, Martling A, Carlsson S, Blomqvist L. Synchronous rectal and prostate cancer \u2013 the impact of MRI on incidence and imaging findings. Eur J Radiol. 2015;84:563\u20137.","DOI":"10.1016\/j.ejrad.2014.12.030"},{"key":"102119","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ejrad.2014.12.030","DOI":"10.1016\/j.ejrad.2014.12.030"},{"key":"102120","doi-asserted-by":"crossref","unstructured":"Seretis C, Seretis F, Liakos N. Multidisciplinary approach to synchronous prostate and rectal cancer: current experience and future challenges. J Clin Med Res. 2014;6:157\u201361.","DOI":"10.14740\/jocmr1796w"},{"key":"102121","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.14740\/jocmr1796w","DOI":"10.14740\/jocmr1796w"},{"key":"102122","doi-asserted-by":"crossref","unstructured":"Doussot A, Vernerey D, Rullier E, Lefevre JH, Meillat H, Cotte E, et al. Surgical management and outcomes of rectal cancer with synchronous prostate cancer: a multicenter experience from the GRECCAR group. Ann Surg Oncol. 2020;27:4286\u201393.","DOI":"10.1245\/s10434-020-08683-4"},{"key":"102123","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1245\/s10434-020-08683-4","DOI":"10.1245\/s10434-020-08683-4"},{"key":"102124","doi-asserted-by":"crossref","unstructured":"Lakkis Z, Vernerey D, Mege D, Faucheron JL, Panis Y, Tuech JJ, et al. Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy. Br J Surg. 2019;106:1087\u201398.","DOI":"10.1002\/bjs.11176"},{"key":"102125","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/bjs.11176","DOI":"10.1002\/bjs.11176"},{"key":"102126","doi-asserted-by":"crossref","unstructured":"Guandalino M, Dupr\u00e9 A, Fran\u00e7ois M, Leroy B, Antomarchi O, Buc E, et al. Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery. J Surg Oncol. 2015;112:802\u20138.","DOI":"10.1002\/jso.24075"},{"key":"102127","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/jso.24075","DOI":"10.1002\/jso.24075"},{"key":"102128","doi-asserted-by":"crossref","unstructured":"Tomminen T, Huhtala H, Kotaluoto S, Veitonm\u00e4ki T, Wirta EV, Hy\u00f6ty M. Surgical and oncological results after rectal resections with or without previous treatment for prostate cancer. Front Surg. 2024;11:1298865.","DOI":"10.3389\/fsurg.2024.1298865"},{"key":"102129","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fsurg.2024.1298865","DOI":"10.3389\/fsurg.2024.1298865"},{"key":"102130","doi-asserted-by":"crossref","unstructured":"Nash GF, Turner KJ, Hickish T, Smith J, Chand M, Moran BJ. Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum. Ann R Coll Surg Engl. 2012;94:456\u201362.","DOI":"10.1308\/003588412X13373405384611"},{"key":"102131","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1308\/003588412X13373405384611","DOI":"10.1308\/003588412X13373405384611"},{"key":"102132","doi-asserted-by":"crossref","unstructured":"Celentano G, Creta M, Napolitano L, Abate M, La Rocca R, Capece M, et al. Prostate cancer diagnosis, treatment and outcomes in patients with previous or synchronous colorectal cancer: a systematic review of published evidence. Diagnostics (Basel). 2022;12(6):1475.","DOI":"10.3390\/diagnostics12061475"},{"key":"102133","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/diagnostics12061475","DOI":"10.3390\/diagnostics12061475"},{"key":"102134","doi-asserted-by":"crossref","unstructured":"Vallancien G, Cathelineau X, Baumert H, Doublet JD, Guillonneau B. Complications of transperitoneal laparoscopic surgery in urology: review of 1,311 procedures at a single center. J Urol. 2002;168:23\u20136.","DOI":"10.1016\/S0022-5347(05)64823-9"},{"key":"102135","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0022-5347(05)64823-9","DOI":"10.1016\/S0022-5347(05)64823-9"},{"key":"102136","doi-asserted-by":"crossref","unstructured":"Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27\u201333.","DOI":"10.1080\/02841860802247664"},{"key":"102137","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/02841860802247664","DOI":"10.1080\/02841860802247664"},{"key":"102138","doi-asserted-by":"crossref","unstructured":"Pan SY, Huang CP, Chen WC. Synchronous\/metachronous multiple primary malignancies: review of associated risk factors. Diagnostics (Basel). 2022;12(3):1940.","DOI":"10.3390\/diagnostics12081940"},{"key":"102139","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/diagnostics12081940","DOI":"10.3390\/diagnostics12081940"},{"key":"102140","doi-asserted-by":"crossref","unstructured":"Rezende LFM, Sa TH, Markozannes G, Rey-Lopez JP, Lee IM, Tsilidis KK, et al. Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases. Br J Sports Med. 2018;52:826\u201333.","DOI":"10.1136\/bjsports-2017-098391"},{"key":"102141","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bjsports-2017-098391","DOI":"10.1136\/bjsports-2017-098391"},{"key":"102142","doi-asserted-by":"crossref","unstructured":"Bowrey DJ, Otter MI, Billings PJ. Rectal infiltration by prostatic adenocarcinoma: report on six patients and review of the literature. Ann R Coll Surg Engl. 2003;85:382\u20135.","DOI":"10.1308\/003588403322520726"},{"key":"102143","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1308\/003588403322520726","DOI":"10.1308\/003588403322520726"},{"key":"102144","doi-asserted-by":"crossref","unstructured":"Kavanagh DO, Quinlan DM, Armstrong JG, Hyland JM, O\u2019Connell PR, Winter DC. Management of synchronous rectal and prostate cancer. Int J Colorectal Dis. 2012;27:1501\u20138.","DOI":"10.1007\/s00384-012-1465-z"},{"key":"102145","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00384-012-1465-z","DOI":"10.1007\/s00384-012-1465-z"},{"key":"102146","unstructured":"NPCR. \u201dMR f\u00f6rst\u201d Hur g\u00e5r det? Nyheter 2021 [cited 2025 February 6]; Available from: https:\/\/npcr.se\/mr-forst-hur-gar-det\/"},{"key":"102147","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403:1027\u201350."},{"key":"102148","doi-asserted-by":"crossref","unstructured":"Arnold M, Pandeya N, Byrnes G, Renehan PAG, Stevens GA, Ezzati PM, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16:36\u201346.","DOI":"10.1016\/S1470-2045(14)71123-4"},{"key":"102149","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1470-2045(14)71123-4","DOI":"10.1016\/S1470-2045(14)71123-4"},{"key":"102150","doi-asserted-by":"crossref","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer \u2013 viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794\u20138.","DOI":"10.1056\/NEJMsr1606602"},{"key":"102151","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMsr1606602","DOI":"10.1056\/NEJMsr1606602"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/42592\/49415","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/42592\/49415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:05:18Z","timestamp":1756404318000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/42592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":54,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.42592","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}